Noveris Health Sciences Announces Appointment Of Nathan Mison As Chair Of Advisory Board
Vancouver, British Columbia – June 12, 2026 – TheNewswire – Noveris Health Sciences Inc. (“Noveris” or the “Company”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce the appointment of Nathan Mison as Chair of the Company’s Advisory Board.
The Advisory Board has been established by the Company’s Board of Directors to provide management and the Board with access to additional external expertise as the Company continues its strategic review of its intellectual property portfolio and related opportunities. The Advisory Board is intended to serve in an advisory capacity only and will not have decision-making authority on behalf of the Company. Its mandate includes providing strategic input, identifying potential opportunities, supporting management’s assessment of relevant industry, regulatory, partnership and commercialization matters, and recommending additional advisory candidates whose expertise may support the Company’s strategic objectives.
Mr. Mison is President and Founding Partner of Diplomat Consulting and currently serves as Chair of TrustBIX Inc. (TSXV: TBIX). He has extensive experience advising organizations operating in regulated industries, with particular expertise in public affairs, stakeholder engagement, regulatory strategy, government relations, and strategic communications.
As Chair of the Advisory Board, Mr. Mison will assist management and the Board in organizing and leading the Advisory Board’s activities, identifying and recommending additional advisory board candidates, and providing strategic input in support of opportunities arising from the Company’s ongoing strategic review process.
“Nathan brings valuable experience working with organizations operating in complex and evolving regulatory environments,” said Jason Birmingham, Chief Executive Officer of Noveris. “His background in public affairs, stakeholder engagement, strategic communications and regulatory matters will provide important perspective as we continue evaluating opportunities identified through our strategic review process. We also look forward to working with Nathan as he helps us build out the Company’s advisory capabilities.”
Mr. Mison commented: “I am pleased to join Noveris as Chair of the Advisory Board and look forward to supporting management and the Board as they continue their evaluation of the Company’s intellectual property portfolio and related opportunities.”
About Nathan Mison
Nathan Mison is President and Founding Partner of Diplomat Consulting, a strategic advisory firm focused on public affairs, stakeholder engagement, government relations, regulatory strategy, and communications. He currently serves as Chair of TrustBIX Inc. and has advised organizations across a variety of regulated and emerging sectors.
ABOUT NOVERIS HEALTH SCIENCES INC.
Noveris Health Sciences Inc. is a biotechnology company focused on the development, advancement, and commercialization of intellectual property, technologies, and therapeutic opportunities addressing significant unmet needs in healthcare. The Company continues to evaluate opportunities to create value through strategic partnerships, licensing arrangements, research collaborations, and related commercial initiatives.
ON BEHALF OF THE BOARD OF DIRECTORS
Jason Birmingham
Chief Executive Officer
For further information
Noveris Health Sciences Inc.
Tel: +1 778-900-NVRS (6877)
Email: [email protected]
Web: www.noveris.health
Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2026 TheNewswire - All rights reserved.